Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...

LILONGWE-(MaraviPost)-President Peter Mutharika says remains committed not to shield anyone involved in the ongoing Public ...

One consultant urologist explains how focal therapy can minimise the risks of side effects such as incontinence and erectile ...

This may not apply in your husband’s case, but it’s worth having the conversation. The two meds Goldstein prescribes for men ...

While sales of Talzenna, which Pfizer acquired in a $14 billion deal, have been “negligible” so far, the new results should ...

Pfizer (PFE) stock is in focus as Xtandi, marketed with Astellas (ALPMF), and cancer drug Talzenna succeed in a Phase 3 trial ...

Fruits are one of the best sources of nutrients to reduce chronic inflammation, which has been linked to heart disease, ...

Of RBM's hide and seek ploy against Amaryllis Hotel purchase probe: A blatant attempt to undermine Parliamentary oversight ...

CEO Jim Clemmer said the company has spent the last several years reshaping its portfolio and operating model, moving away ...

Prostate cancer is one of the most common cancers affecting men around the world. In many countries, including Germany, it is the most frequently diagnosed cancer in men. Each year, about 65,000 men ...

An investigational approach to diagnosis of prostate cancer uses sound waves to extract "bubbles of information" from cells. (Cancer Research UK) In a first-ever clinical trial, a treatment strategy ...

Please provide your email address to receive an email when new articles are posted on . Pylarify TruVu is a new formulation of piflufolastat F 18 injection, which originally earned FDA approval in ...